制备了一些可能与胆碱具有类似构象的α-苯基-β-(3,4-二甲氧基)苯乙胺衍生物。研究了鱼雷电器官对胆碱乙酰基转移酶的体外抑制作用。这些化合物具有不同程度的抑制作用。最有效的抑制剂是N,N,N,-三甲基-α-苯基-β-(3,4-二甲氧基)苯乙铵++ +碘化物,I50为1.3 X 10(-5)M。抑制胆碱乙酰转移酶还确定了来自斜纹夜蛾幼虫脑的来源用于比较研究。前述化合物在来自该来源的胆碱乙酰基转移酶上的I50为9 X 10(-6)M。
制备了一些可能与胆碱具有类似构象的α-苯基-β-(3,4-二甲氧基)苯乙胺衍生物。研究了鱼雷电器官对胆碱乙酰基转移酶的体外抑制作用。这些化合物具有不同程度的抑制作用。最有效的抑制剂是N,N,N,-三甲基-α-苯基-β-(3,4-二甲氧基)苯乙铵++ +碘化物,I50为1.3 X 10(-5)M。抑制胆碱乙酰转移酶还确定了来自斜纹夜蛾幼虫脑的来源用于比较研究。前述化合物在来自该来源的胆碱乙酰基转移酶上的I50为9 X 10(-6)M。
Substituted (1,2-Diarylethyl)amide Acyl-CoA:Cholesterol Acyltransferase Inhibitors: Effect of Polar Groups on in Vitro and in Vivo Activity
作者:John W. Clader、Joel G. Berger、Robert E. Burrier、Harry R. Davis、Martin Domalski、Sundeep Dugar、Timothy P. Kogan、Brian Salisbury、Wayne Vaccaro
DOI:10.1021/jm00010a004
日期:1995.5
Substituted (1,2-diarylethyl)amides have been prepared and evaluated for their ability to inhibit microsomal acyl-CoA:cholesterol acyltransferase activity in vitro and to lower hepatic cholesteryl ester content in vivo in a cholesterol-fed hamster. Simple unsubstituted (diarylethyl)amides were potent inhibitors in vitro but showed poor activity in vivo. Introduction of polar groups at specific locations
N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme
申请人:Schering Corporation
公开号:US05124337A1
公开(公告)日:1992-06-23
N-acyltetrahydroisoquinolines including novel compounds of the formula ##STR1## wherein R.sup.1 is a C10-C25 alkyl chain; a substituted C10-C25 alkyl chain; an interrupted C10-C25 alkyl chain; a substituted interrupted C10-C25 alkyl chain; diphenylamino; di-(R.sup.2 -substituted phenyl)amino; di-(heteroaryl)amino; di-R.sup.2 -substituted heteroary)amino; diphenylmethyl; or di-(R.sup.2 -substituted phenyl)methyl; R.sup.2 is hydroxy, lower alkyl, lower alkoxy, halogeno, amino, lower alkylamino or di-(lower alkyl)amino; R.sup.3, R.sup.4 and R.sup.5 are independently H or --(CH.sub.2 .sub.n --Ar; Ar is phenyl, R.sup.2 -substituted phenyl, heteroaryl or R.sup.2 -substituted heteroaryl; n=0,1 or 2; m=0,1 or 2; or a pharmaceutically acceptable salt thereof, useful in the treatment of atherosclerosis are disclosed.
(±)α-Phenyl-β-(3,4-dimethoxy)- and (±)α-Phenyl-β-(3,4-dihydroxy)phenethylamines: Potential Probes for Nicotinic Acetylcholine Receptor-Ion Channel Molecule from Torpedo Electric Organ
作者:Ragab M. Shafik、Raafat Soliman、Soad A. El-Hawash、Samia A. El-Dardiry、Shebl Sherby
DOI:10.1002/jps.2600761017
日期:1987.10
N-alkyl derivatives of (+/-)alpha-phenyl-beta-(3,4-dimethoxy)- and (+/-)alpha-phenyl-beta-(3,4-dihydroxy)-phenethylamines was achieved. These compounds were shown to bear certain structural features of acetylcholine (ACh), as well as phencyclidine (PCP). The latter was reported to act as a specific probe for the nicotinic ACh receptor-ionchannelmoleculefromTorpedoelectricorgan. Biochemical binding
N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase
申请人:SCHERING CORPORATION
公开号:EP0514851A1
公开(公告)日:1992-11-25
N-acyltetrahydroisoquinolines including novel compounds of the formula
wherein R¹ is a C10-C25 alkyl chain; a substituted C10-C25 alkyl chain; an interrupted C10-C25 alkyl chain; a substituted interrupted C10-C25 alkyl chain; diphenylamino; di-(R²-substituted phenyl)amino; di-(heteroaryl)amino; di-(R²-substituted heteroaryl)amino; diphenylmethyl; or di-(R²-substituted phenyl)methyl;
R² is hydroxy, lower alkyl, lower alkoxy, halogeno, amino, lower alkylamino or di-(lower alkyl)amino;
R³, R⁴ and R⁵ are independently H or -(CH₂)n-Ar;
Ar is phenyl, R²-substituted phenyl, heteroaryl or R²-substituted heteroaryl;
n= 0,1 or 2;
m= 0,1 or 2;
or a pharmaceutically acceptable salt thereof, useful in the treatment of atherosclerosis are disclosed.